Transine Therapeutics Closes Extended Seed Funding of £9.1 …
WEBJun 2, 2021 · CAMBRIDGE, United Kingdom, June 2, 2021 /PRNewswire/ -- Transine Therapeutics ('Transine'), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP®...
Transine Therapeutics Announces Final Closing of its Seed …
WEBMay 31, 2022 · Transine Therapeutics is an RNA platform company developing a novel class of therapeutic RNAs (SINEUPs) capable of upregulating protein expression with a superior level of control and...
Transine $12.8 Million Seed Funding to Advance Novel Class of ...
WEBJun 2, 2021 · U.K.-based Transine Therapeutics emerged from stealth and Rraised $12.8 million (£9.1 million) in seed funding to advance its proprietary platform towards building a pipeline of novel mRNA-targeted therapeutics initially focused on the central nervous system and ophthalmology applications.
Harness Therapeutics secures additional £4 million funding to …
WEBNov 28, 2023 · Harness, formerly operating as Transine, broadens its approach to physiological protein upregulation through post-transcriptional modulation of protein synthesis. Refined focus on ...
Transine Therapeutics Announces Final Closing of its Seed
WEBCambridge, UK, 31 May 2022: Transine Therapeutics (‘ Transine ’), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP ® platform technology, announces that it has successfully raised £4.6 million in …
Transine Therapeutics closes extended seed funding of £9.1m to …
WEBTransine Therapeutics, a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® platform technology, announces that it successfully secured £9.1 million in seed funding.
Transine Therapeutics poised for growth with new CSO hire and …
WEBJun 23, 2022 · Transine Therapeutics is developing a novel class of therapeutic RNAs (SINEUPs ®) capable of upregulating protein expression with a superior level of control and specificity across an...
Transine Therapeutics Appoints Industry Veteran Jan ... - PR …
WEBJul 5, 2021 · Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of...
Transine Therapeutics Closes Extended Seed Funding of £9.1 …
WEBTransine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® platform technology, announces that it successfully secured £9.1 million in seed funding.
Transine Therapeutics Announces Final Closing of its Seed …
WEBMay 31, 2022 · Transine Therapeutics (‘Transine’), a biotechnology company developing a novel class of therapeutic RNAs based on its pioneering SINEUP® platform technology, announces that it has successfully raised £4.6 million in additional seed funding.